Endometriosis is a chronic inflammatory disease that causes pain and infertility in women of reproductive age.
Objective:
To investigate the pathologic pathways in endometrial stromal and epithelial cells that contribute to the manifestation of endometriosis.
Design:
In vitro cellular and molecular analyses of isolated eutopic endometrial stromal and epithelial cells.
Methods:
Eutopic stromal and epithelial cells from endometriotic and normal patients were isolated by fluorescence-activated cell sorting for paired sibling RNA sequencing and microRNA microarray. Aberrant pathways were identified using ingenuity pathway analysis networks and confirmed with in vitro modulation of the affected pathways in stromal and epithelial cell cultures.
Results:
Both stromal versus epithelial cell types and paired endometriotic versus normal samples exhibited distinct hierarchical clustering. Compared to normal samples, there were 151 and 215 differentially expressed genes in the endometriotic stromal and epithelial populations, respectively, and concomitantly 9 and 16 differentially expressed microRNAs. Overall, endometriotic stromal and epithelial cells revealed distinct defects. In endometriotic stromal cells, key decidualization genes Zinc finger E-box Binding protein 1 (ZEB1), Heart And Neural crest Derivatives expressed 2 (HAND2), WNT4, and Interleukin 15 (IL-15) were found to be downregulated and Periostin (POSTN) and Matrix Metallopeptidase 7 (MMP7) were upregulated. Specifically, ZEB1 was downregulated in stromal cells by aberrant elevation in miR-200b. In contrast, ZEB1 was found to be upregulated in endometriotic epithelial cells through associated upregulation of transforming growth factor β1 (TGFβ1), inducer of the TGFβ1–Bone Morphogenetic Protein 2 (BMP2)–MMP2–Prostaglandin-endoperoxide Synthase 2 (COX2)–ZEB1 pathway, which activates epithelial–mesenchymal transition.
Conclusion:
Manifestation of endometriosis involves dysregulation of unique molecular pathways within the diseased endometrial stromal and epithelial cells in the endometrium. Targeting the cell type–specific defects may offer a novel approach to treating endometriosis.
BrosensIPuttemansPBenagianoG. Endometriosis: a life cycle approach?Am J Obstet Gynecol. 2013;209(4):307–316.
5.
BrosensIBrosensJBenagianoG. Neonatal uterine bleeding as antecedent of pelvic endometriosis. Hum Reprod. 2013;28(11):2893–2897.
6.
LesseyBLebovicDTaylorR. Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects. Semin Reprod Med. 2013;31(2):109–124.
7.
HadfieldRMardonHBarlowDKennedyS. Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod. 1996;11(4):878–880.
8.
MaruyamaTYoshimuraY. Stem cell theory for the pathogenesis of endometriosis. Front Biosci. 2012;4E(8):2754–2763.
9.
AznaurovaYZhumataevMRobertsTAliperAZhavoronkovA. Molecular aspects of development and regulation of endometriosis. Reprod Biol Endocrinol. 2014;12(1):50.
10.
GargettCESchwabKEBrosensJJPuttemansPBenagianoGBrosensI. Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis. Mol Hum Reprod. 2014;20(7):591–598.
11.
DuHTaylorHS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells. 2007;25(8):2082–2086.
12.
ZanattaARochaACarvalhoF. The role of the Hoxa10/HOXA10 gene in the etiology of endometriosis and its related infertility: a review. J Assist Reprod Genet. 2010;27(12):701–710.
13.
SampsonJ. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol. 1927;14(4):422–469.
14.
MarshEELauferMR. Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly. Fertil Steril. 2005;83(3):758–760.
15.
MatsuuraKOhtakeHKatabuchiHOkamuraH. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest. 1999;47(suppl 1):18–22.
16.
FigueiraPGMAbrãoMSKrikunGTaylorH. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann NY Acad Sci. 2011;1221(1):10–17.
17.
WrenJDWuYGuoSW. A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium. Hum Reprod. 2007;22(8):2093–2102.
18.
Ohlsson TeagueEMCVan der HoekKHVan der HoekMB. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol. 2009;23(2):265–275.
19.
MatsuzakiS. DNA microarray analysis in endometriosis for development of more effective targeted therapies. Front Biosci. 2011;3E(3):1139–1153.
20.
PainterJNAndersonCANyholtDR. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 2011;43(1):51–54.
21.
FilighedduNGregnaninIPorporatoPE. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol. 2010;2010:369549.
22.
SunPRJiaSZLinHLengJHLangJH. Genome-wide profiling of long noncoding ribonucleic acid expression patterns in ovarian endometriosis by microarray. Fertil Steril. 2014;101(4):1038–1046.e7.
23.
MatsuzakiSCanisMVaurs-BarrièreCBoespflug-TanguyODastugueBMageG. DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. Fertil Steril. 2005;84(suppl 2):1180–1190.
24.
BurneyROTalbiSHamiltonAE. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(8):3814–3826.
25.
GrahamAFalconeTNothnickWB. The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival. Hum Reprod. 2015;30(3):642–652.
26.
SherwinJRASharkeyAMMihalyiASimsaPCatalanoRDD’HoogheTM. Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis. Hum Reprod. 2008;23(5):1063–1068.
27.
MeolaJRosa e SilvaJCDentilloDB. Differentially expressed genes in eutopic and ectopic endometrium of women with endometriosis. Fertil Steril. 2010;93(6):1750–1773.
28.
RosserMDHarisPIAnkrettDNKonjeJC. The emerging role of epigenetics and miRNAs in endometriosis. Expert Rev Obstet Gynecol. 2011;6(4):431–450.
29.
KennedySH. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol. 1999;82(2):129–133.
30.
GuoSW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.
31.
BaccarelliABollatiV. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21(2):243–251.
32.
LeeBDuHTaylorHS. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod. 2009;80(1):79–85.
33.
XueQLinZChengYH. Promoter methylation regulates estrogen receptor 2 in endometrium and endometriosis. Biol Reprod. 2007;77(4):681–687.
34.
DysonMTRoqueiroDMonsivaisD. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014;10(3):e1004158.
35.
WuYStrawnEBasirZHalversonGGuoSW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril. 2007;87(1):24–32.
36.
NasuKKawanoYTsukamotoY. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res. 2011;37(7):683–695.
37.
NaqviHIlaganYKrikunGTaylorHS. Altered genome-wide methylation in endometriosis. Reprod Sci. 2014;21(10):1237–1243.
38.
Colon-DiazMBaez-VegaPGarciaM. HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci. 2012;19(5):483–492.
39.
KawanoYNasuKLiH. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod. 2011;26(9):2486–2498.
40.
NasuKKawanoYKaiK. Aberrant histone modification in endometriosis. Front Biosci. 2014;19:1202–1214.
41.
MonteiroJBColón-DíazMGarcíaM. Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications. Reprod Sci. 2014;21(3):305–318.
42.
TaftRJPangKCMercerTRDingerMMattickJS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220(2):126–139.
43.
SantamariaXTaylorH. MicroRNA and gynecological reproductive diseases. Fertil Steril. 2014;101(6):1545–1551.
OhlssonTEPrintCGHullML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update. 2010;16(2):142–165.
46.
HawkinsSMCreightonCJHanDY. Functional microRNA involved in endometriosis. Mol Endocrinol. 2011;25(5):821–832.
47.
PanQCheginiN. MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med. 2008;26(6):479–493.
48.
Braza-BoïlsAMarí-AlexandreJGilabertJ. MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors. Hum Reprod. 2014;29(5):978–988.
49.
OkamotoMNasuKAbeW. Enhanced miR-210 expression promotes the pathogenesis of endometriosis through activation of signal transducer and activator of transcription 3. Hum Reprod. 2015;30(3):632–641.
50.
KaoLCGermeyerATulacS. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144(7):2870–2881.
51.
BurneyROHamiltonAEAghajanovaL. MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod. 2009;15(10):625–631.
52.
ZafrakasMTarlatzisBCStreichertT. Genome-wide microarray gene expression, array-CGH analysis, and telomerase activity in advanced ovarian endometriosis: a high degree of differentiation rather than malignant potential. Int J Mol Med. 2008;21(3):335–344.
53.
OgerFGheeraertCMogilenkoD. Cell-specific dysregulation of MicroRNA expression in obese white adipose tissue. J Clin Endocrinol Metab. 2014;99(8):2821–2833.
54.
JovičićARoshanRMoisoiN. Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes. J Neurosci. 2013;33(12):5127–5137.
55.
McCallMNKentOAYuJFox-TalbotKZaimanALHalushkaMK. MicroRNA profiling of diverse endothelial cell types. BMC Med Genomics. 2011;4(1):1–13.
56.
GellersenBBrosensIABrosensJJ. Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives. Semin Reprod Med. 2007;25(6):445–453.
57.
Guzeloglu-KayisliOKayisliUATaylorHS. The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med. 2009;27(1):62–79.
58.
GrahamCLalaP. Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol. 1992;70(10-11):867–874.
59.
LockwoodCKrikunGSchatzF. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol. 1999;17(1):45–51.
60.
NorwitzER. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod Biomed Online. 2006;13(4):591–599.
KuriharaILeeDKPetitFG. COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity. PLoS Genetics. 2007;3(6):e102.
63.
BulunSEChengYHPavoneME. 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis. Semin Reprod Med. 2010;28(1):44–50.
64.
LeeKYJeongJWTsaiSYLydonJPDeMayoFJ. Mouse models of implantation. Trend Endocrinol Metab. 2007;18(6):234–239.
65.
BulunSE. Endometriosis. N Engl J Med. 2009;360(3):268–279.
66.
LiQKannanADasA. WNT4 acts downstream of BMP2 and functions via β-catenin signaling pathway to regulate human endometrial stromal cell differentiation. Endocrinology. 2013;154(1):446–457.
67.
GregoryGDVakocCRRozovskaiaT. Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes. Mol Cell Biol. 2007;27(24):8466–8479.
68.
KlemmtPACarverJGKennedySHKoninckxPRMardonHJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril. 2006;85(3):564–572.
69.
LashGEBulmerJN. Do uterine natural killer (uNK) cells contribute to female reproductive disorders?J Reprod Immunol. 2011;88(2):156–164.
70.
SalamonsenLHannanNDimitriadisE. Cytokines and chemokines during human embryo implantation: roles in implantation and early placentation. Semin Reprod Med. 2007;25(6):437–444.
71.
WaldmannTATagayaY. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Ann Rev Immunol. 1999;17(1):19–49.
72.
SozzaniSAllavenaPVecchiAMantovaniA. The role of chemokines in the regulation of dendritic cell trafficking. J Leuk Biol. 1999;66(1):1–9.
73.
SchiraldiMRaucciAMuñozLM. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med. 2012;209(3):551–563.
74.
KalesnikoffJGalliSJ. New developments in mast cell biology. Nat Immunol. 2008;9(11):1215–1223.
75.
ThiruchelvamUDransfieldISaundersPTKCritchleyHOD. The importance of the macrophage within the human endometrium. J Leukoc Biol. 2013;93(2):217–225.
76.
OkadaHNakajimaTSanezumiMIkutaAYasudaKKanzakiH. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. J Clin Endocrinol Metab. 2000;85(12):4765–4770.
77.
GodboleGModiD. Regulation of decidualization, interleukin-11 and interleukin-15 by homeobox A 10 in endometrial stromal cells. J Reprod Immunol. 2010;85(2):130–139.
78.
LeeJYLeeMLeeSK. Role of endometrial immune cells in implantation. Clin Exp Reprod Med. 2011;38(3):119–125.
79.
CartwrightJEBalarajahG. Trophoblast interactions with endothelial cells are increased by interleukin-1[beta] and tumour necrosis factor [alpha] and involve vascular cell adhesion molecule-1 and [alpha]4[beta]1. Exp Cell Res. 2005;304(1):328–336.
80.
GellersenBReimannKSamalecosAAupersSBambergerAM. Invasiveness of human endometrial stromal cells is promoted by decidualization and by trophoblast-derived signals. Hum Reprod. 2010;25(4):862–873.
81.
FisherSJDamskyCH. Human cytotrophoblast invasion. Semin Cell Biol. 1993;4(3):183–188.
82.
BrosensIPijnenborgRVercruysseLRomeroR. The Great Obstetrical Syndromes are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201.
83.
DuncanWCShawJLVBurgessSMcDonaldSECritchleyHODHorneAW. Ectopic pregnancy as a model to identify endometrial genes and signaling pathways important in decidualization and regulated by local trophoblast. PLoS One. 2011;6(8):e23595.
84.
AghajanovaLTatsumiKHorcajadasJA. Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod. 2011;84(4):801–815.
85.
NovembriRBorgesLECarrarelliP. Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis. J Clin Endocrinol Metab. 2011;96(4):1145–1150.
86.
ShenLLiuPZhangPZhangXCuiJ. Characterization of periostin expression in human endometrium and endometriotic lesions. Gynecol Endocrinol. 2012;28(10):815–818.
87.
YangHZhouYEdelshainBSchatzFLockwoodCJTaylorHS. FKBP4 is regulated by HOXA10 during decidualization and in endometriosis. Reproduction. 2012;143(4):531–538.
88.
EstellaCHerrerIMoreno-MoyaJM. miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoS One. 2012;7(7):e41080.
89.
GellersenBKempfRTelgmannR. Human endometrial stromal cells express novel isoforms of the transcriptional modulator CREM and up-regulate ICER in the course of decidualization. Mol Endocrinol. 1997;11(1):97–113.
90.
TeklenburgGSalkerMHeijnenCJMacklonNSBrosensJJ. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection. Mol Hum Reprod. 2010;16(12):886–895.
91.
LockwoodCKrikunGRahmanMCazeRBuchwalderLSchatzF. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin Thromb Hemost. 2007(01):111–117.
92.
KaufmannPBlackSHuppertzB. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1–7.
93.
LucasESDyerNPMurakamiK. Loss of endometrial plasticity in recurrent pregnancy loss. Stem cells. 2016;34(2):346–356.
94.
BrabletzSBrabletzT. The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?EMBO Rep. 2010;11(9):670–677.
95.
RenthalNEChenCCWilliamsKCGerardRDPrange-KielJMendelsonCR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci. 2010;107(48):20828–20833.
96.
Romero-PerezLLopez-GarciaMADiaz-MartinJ. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma. Mod Pathol. 2013;26(11):1514–1524.
97.
HaraguchiHSaito-FujitaTHirotaY. MicroRNA-200a locally attenuates progesterone signaling in the cervix, preventing embryo implantation. Mol Endocrinol. 2014;28(7):1108–1117.
98.
GregoryPABertAGPatersonEL. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10(5):593–601.
99.
HillLBrowneGTulchinskyE. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer. 2013;132(4):745–754.
100.
DykxhoornDM. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res. 2010;70(16):6401–6406.
101.
WangGGuoXHongW. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci. 2013;110(8):2858–2863.
102.
YaoDDaiCPengS. Mechanism of the mesenchymal–epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res. 2011;9(12):1608–1620.
103.
BarraganFIrwinJCBalayanS. Human endometrial fibroblasts derived from mesenchymal progenitors inherit progesterone resistance and acquire an inflammatory phenotype in the endometrial niche in endometriosis. Biol Reprod. 2016;94(5):118, 1–20.
104.
BulunSEChengYHPavoneME. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med. 2010;28(1):36–43.
105.
BulunSEChengYHYinP. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006;248(1-2):94–103.
106.
EatonJLUnnoKCaraveoMLuZKimJJ. Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis. J Clin Endocrinol Metab. 2013;98(12):e1871–e1879.
107.
MorraLMochH. Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update. Virchows Arch. 2011;459(5):465–475.
108.
ShindohHOkadaHTsuzukiTNishigakiAKanzakiH. Requirement of heart and neural crest derivatives–expressed transcript 2 during decidualization of human endometrial stromal cells in vitro. Fertil Steril. 2014;101(6):1781–1790.e5.
109.
HevirNVoukKŠinkovecJRibič-PuceljMRižnerTL. Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis. Chem Biol Interact. 2011;191(1-3):217–226.
110.
ChengYHUtsunomiyaHPavoneMEYinPBulunSE. Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms. J Mol Endocrinol. 2011;46(2):139–153.
111.
WetendorfMDeMayoFJ. The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network. Mol Cell Endocrinol. 2011;357(1-2):108–118.
112.
SmithKAlnifaidyRWeiQNiemanLK. Endometrial Indian Hedgehog expression is decreased in women with endometriosis. Fertil Steril. 2011;95(8):2738–2741.e3.
113.
LargeMJDeMayoFJ. The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling. Mol Cell Endocrinol. 2012;358(2):155–165.
114.
KatohYKatohM. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). Int J Mol Med. 2008;22(3):271–275.
115.
HillmanRTFengBYNiJ. Neuropilins are positive regulators of Hedgehog signal transduction. Genes Dev. 2011;25(22):2333–2346.
116.
FuLLockhartMGAmirMMWinnallWRRogersPAWGirlingJE. Differential TGFB1-signalling in endometrium from women with endometriosis: importance of appropriate housekeeping genes. J Endometr Pelvic Pain Disord. 2014;6(1):41–54.
117.
GregoryPABrackenCPSmithE. An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011;22(10):1686–1698.
118.
ProestlingKBirnerPGamperlS. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis. Reprod Biol Endocrinol. 2015;13(1):75.
119.
BartleyJJülicherAHotzBMechsnerSHotzH. Epithelial to mesenchymal transition (EMT) seems to be regulated differently in endometriosis and the endometrium. Arch Gynecol Obstet. 2013;289(4):871–881.
120.
FuxeJKarlssonMCI. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol. 2012;22(5-6):455–461.
121.
MoustakasAHeldinCH. Induction of epithelial–mesenchymal transition by transforming growth factor β. Semin Cancer Biol. 2012;22(5-6):446–454.
122.
HurtESaykallyJAnoseBKalliKSandersM. Expression of the ZEB1 (δEF1) transcription factor in human: additional insights. Mol Cell Biochem. 2008;318(1-2):89–99.
123.
AbeWNasuKNakadaCKawanoYMoriyamaMNaraharaH. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod. 2013;28(3):750–761.
124.
AnoseBMSandersMM. Androgen receptor regulates transcription of the ZEB1 transcription factor. Int J Endocrinol. 2011;2011:903918.
125.
SinghMSpoelstraNSJeanA. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol. 2008;21(7):912–923.
126.
GregoryPABrackenCPBertAGGoodallGJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle. 2008;7(20):3112–3117.
127.
ZhangGJZhouTTianHPLiuZLXiaSS. High expression of ZEB1 correlates with liver metastasis and poor prognosis in colorectal cancer. Oncol Lett. 2013;5(2):564–568.
128.
LebovicDIBaldocchiRAMuellerMDTaylorRN. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril. 2002;78(4):849–854.
129.
WellnerUSchubertJBurkUC. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11(12):1487–1495.
130.
EggersJCMartinoVReinboldR. microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4. Reprod BioMed Online. 2016;32(4):434–445.
131.
NasarrePGemmillRMPotironVA. Neuropilin-2 is upregulated in lung cancer cells during TGFβ1–induced epithelial–mesenchymal transition. Cancer Res. 2013;73(23):7111–7121.
132.
AxelrodHPientaKJ. Axl as a mediator of cellular growth and survival. Oncotarget. 2014;5(19):8818–8852.
133.
AsieduMKBeauchamp-PerezFDIngleJNBehrensMDRadiskyDCKnutsonKL. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells. Oncogene. 2014;33(10):1316–1324.
134.
GjerdrumCTironCHøibyT. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci. 2010;107(3):1124–1129.
135.
SunWSMisaoRIwagakiSFujimotoJTamayaT. Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases, Axl and Sky, in human uterine endometrium and ovarian endometriosis. Mol Hum Reprod. 2002;8(6):552–558.
136.
HondaHBarruetoFFGogusevJImDDMorinPJ. Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis. Reprod Biol Endocrinol. 2008;6(1):1–13.
137.
Torres-VázquezJGitlerADFraserSD. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell. 2004;7(1):117–123.
138.
SaareMRekkerKLaisk-PodarT. High-throughput sequencing approach uncovers the miRNome of peritoneal endometriotic lesions and adjacent healthy tissues. PLoS One. 2014;9(11):e112630.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
